Tab. I.

Studies on circulating miRNAs as potential biomarkers of ovarian cancer

Author/Reference no.	Year	Ovarian cancer type	Control	Type of sample	Up-regulated	Down-regulated
Taylor and Gercel-Taylor [50]	2008	Serous	Benign ovarian tumors	Exosomal serum miRNA	miR-21, miR-141, miR-200a, miR-200b, mir-200c, miR-203, miR-205, miR-214
Resnick et al. [48]	2008	Generally epithelial ovarian cancer	Healthy controls	Serum miRNA	miR-21, miR-92, miR-93, miR-126, miR-29a	miR-155, miR-127, miR-99b
Kan et al. [51]	2012	Serous (high grade)	Healthy controls	Serum miRNA	miR-200a, miR-200b, miR-200c
Chung et al. [52]	2013	Serous	Healthy controls	Serum miRNA		miR-132, miR-26a, Let-7b, mir-145
Suryawanshi et al. [46]	2013	Endometrioid/Serous	Healthy controls/Endometriosis	Plasma miRNA	miR-16, miR-21, miR-191, miR-4284
Ji et al. [53]	2014	Generally epithelial ovarian cancer	Healthy controls/Benign ovarian tumors	Serum miRNA	miR-22, miR-93
Shapira et al. [54]	2014	Serous	Healthy controls/Benign ovarian tumors	Plasma miRNA		miR-106b, miR-126, miR-150, miR-17, miR-20a, and miR-92a